Table 3.
Associations of Serum me-NAM Concentrations With Obesity and Diabetes
| Serum me-NAM (+1 ng/mL), log |
||||||
|---|---|---|---|---|---|---|
| All (n = 1160) |
Men (n = 691) |
Women (n = 469) |
||||
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |
| Overweight/obesity | 3.04 (1.61–5.73) | <.001 | 2.36 (1.10–5.08) | .03 | 5.78 (1.78–18.76) | .004 |
| Diabetes | 1.53 (1.14–2.05) | .005 | 1.56 (1.10–2.22) | .01 | 1.86 (1.05–3.31) | .03 |
In a multiple logistic regression model, ORs (95% CIs) were adjusted for age, sex (not in men and women), BMI (not for overweight/obesity), systolic BP, current smoking and alcohol intake, fasting plasma glucose (not for diabetes), serum ALT and GGT, creatinine, total and LDL cholesterol, and triglycerides.